Product Design, Manufacturing & Innovation Resources

最新の出版物とバイオインフォマティクスに関する特許

Bioinformatics Publications Patents

ヒント:以下の選択肢に加えて、2つのデータベース全体を検索およびフィルタリングできます。

> 無料の出版物検索ツール < 著者、トピック、キーワード、日付、または雑誌名で検索できます。

> 無料特許検索ツール < 欧州特許庁の英語による特許情報。

バイオインフォマティクス
バイオインフォマティクスは、計算手法と統計的手法を組み合わせて複雑な生物学的データを分析し、分子機能や疾患メカニズムに関する知見を得る学問である。

バイオインフォマティクスは、計算手法と統計的手法を統合し、生物学的データ、特に大規模なゲノム、トランスクリプトーム、プロテオーム、メタボロームデータセットを分析・解釈します。この分野では、配列アライメント、ゲノムアセンブリ、遺伝子発現プロファイリング、タンパク質構造予測、分子間相互作用ネットワークなどを扱い、分子機能、進化関係、疾患メカニズムに関する知見を深めます。アルゴリズム開発、機械学習アプリケーション、ハイスループットデータ処理の進歩により、包括的なアノテーション、バリアント解釈、システムレベルのモデリングが可能になります。本コレクションは、生物学研究と精密医療の発展に不可欠な計算ツール、データベース管理、分析パイプライン、統合的アプローチに焦点を当てた最新の科学論文と特許取得済みのイノベーションをまとめたものです。

これは、バイオインフォマティクスに関する英語の世界中の出版物と特許の最新のセレクションです。多数の科学オンラインジャーナルの中から、ゲノム配列、配列アライメント、タンパク質構造予測、系統発生、遺伝子発現、次世代シーケンシング、バイオインフォマティクス、計算ゲノム、トランスクリプトーム、メタゲノム、プロテオミクスデータ解析、分子ドッキング、生物学的データベース、構造バイオインフォマティクス、ゲノムアノテーション、バリアントコール、エピゲノム、システム生物学、比較ゲノム、機能ゲノム、RNA-Seq解析、生物統計学、計算生物学、バイオマーカー発見、パスウェイ解析、メタボロミクスに分類され、焦点を絞っています。

Regulatory nucleic acid molecules for enhancing gene expression in plants

Patent published on the 2026-06-04 in WO under Ref WO2026114881 by BASF SE [DE] (Meulewaeter Frank [be], Davis Erin [be])

Abstract: The current disclosure generally relates to the technical field of plant molecular biology and provides methods for the production of high expressing promoters and the production of plants with enhanced expression of nucleic acids wherein one or more nucleic acid expression enhancing nucleic acid (NEENA) is functionally linked to said promoters and/or introduced into plants.[...]


Our summary: This disclosure focuses on enhancing gene expression in plants using regulatory nucleic acid molecules. It details methods for producing high-expressing promoters. The approach involves linking nucleic acid expression enhancing nucleic acids to these promoters in plants.

nucleic acid, gene expression, plant molecular biology, promoters

Patent

Aptamer specifically binding to cell-derived extracellular vesicles and method for discovering extracellular vesicle-specific biomarker using same

Patent published on the 2026-06-04 in WO under Ref WO2026117034 by KONKUK UNIV INDUSTRY ACADEMY COOPERATION FOUNDATION [KR] (Park Ki Soo [kr], Lee Eun Sung [kr], Jun Jimin [kr], Cha Byung Seok [kr], Kim Junhyeong [kr])

Abstract: The present invention relates to an aptamer specifically binding to cell-derived extracellular vesicles and a method for discovering an extracellular vesicle-specific biomarker using same. Specifically, the present invention relates to an aptamer specifically binding to cancer cell-derived extracellular vesicles, and a method for discovering an extracellular vesicle-specific biomarker using same. Unlike prior art requiring immobilization, a method for selecting an aptamer specifically binding to[...]


Our summary: The invention presents an aptamer that binds specifically to cancer cell-derived extracellular vesicles. It includes a method for discovering extracellular vesicle-specific biomarkers without immobilization, maintaining the three-dimensional structure. This approach facilitates novel biomarker discovery and target protein verification for diagnosis and drug development.

Aptamer, extracellular vesicles, biomarker discovery, cancer

Patent

Rhamnolipids for modified gene expression during wound healing

Patent published on the 2026-06-04 in WO under Ref WO2026117688 by STEPAN CO [US] (Strout Kelly [us], Savanhu Faith [us], Sanders Mitch [us])

Abstract: The technology presented herein, in general, relates to the use of biosurfactants, such as rhamnolipids, for treating and/or accelerating the healing of wounds. More particularly, the present technology relates to a method for treating chronic and acute wounds, by applying a composition comprising a mixture of rhamnolipids to the wound, wherein application of the composition facilitates coordinated gene expression associated with wound healing.[...]


Our summary: Rhamnolipids are used to enhance gene expression during wound healing. The method involves applying a rhamnolipid composition to wounds. This approach aims to treat both chronic and acute wounds effectively.

Rhamnolipids, biosurfactants, gene expression, wound healing

Patent

Prediction of stage and survival using isoform expression in gastric adenocarcinoma

Patent published on the 2026-06-04 in US under Ref US20260155253 by UNIV OF SOUTH FLORIDA [US] (Kuo Paul [us], Liang Yifan [us], Lien Kyle [us])

Abstract: Various processes, methods and systems are provided herein for assisting patients, medical providers and other personnel in predicting cancer stage and cancer survival. The systems and methods include determining an indication of a preliminary cancer diagnosis of a given type of cancer for a patient, receiving results of transcriptional sequencing analysis, extracting a set of isoform expression information from transcriptomic data, processing a cancer stemness isoform dataset for a patient, and[...]


Our summary: The content discusses methods for predicting cancer stage and survival in gastric adenocarcinoma using isoform expression. It involves analyzing transcriptional sequencing data and extracting relevant isoform information. The goal is to assist patients and medical providers in making informed decisions based on cancer diagnosis.

isoform expression, gastric adenocarcinoma, cancer prediction, transcriptomic data

Patent

Galnac oligonucleotide conjugate for inhibiting c5 gene expression

Patent published on the 2026-05-28 in WO under Ref WO2026108942 by CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD [CN] (Zhang Xueyan [cn], Wang Lingyu [cn], Su Xiaoye [cn], Zhao Chenglong [cn])

Abstract: Provided are an oligonucleotide conjugate comprising a GalNAc derivative, a pharmaceutical composition comprising the oligonucleotide conjugate, and use of the oligonucleotide conjugate or the pharmaceutical composition.[...]


Our summary: The content discusses a GalNAc oligonucleotide conjugate designed to inhibit C5 gene expression. It includes details about the conjugate, its pharmaceutical composition, and its applications. The focus is on the development and use of this therapeutic approach.

GalNAc, oligonucleotide, gene expression, pharmaceutical composition

Patent

Products and methods for full-length smchd1 expression using split inteins

Patent published on the 2026-05-21 in WO under Ref WO2026107323 by RESEARCH INST AT NATIONWIDE CHILDRENS HOSPITAL [US] (Harper Scott Q [us], Thangaraj Merlin Premalatha [us])

Abstract: Nucleic acids, vectors, compositions, systems, and methods for expressing a structural maintenance of chromosomes hinge domain containing 1 (SMCHD1) polypeptide to epigenetically silence double homeobox 4 (DUX4) for the treatment of a disease or disorder associated with DUX4 are provided. DUX4 regulates gene expression and plays a role in development, muscular dystrophy (including, but not limited to, facioscapulohumeral dystrophy (FSHD)), a cancer, or Bosma arhinia microphthalmia syndrome (BAMS[...]


Our summary: This content discusses products and methods for expressing the SMCHD1 polypeptide using split inteins. It highlights the role of DUX4 in diseases like muscular dystrophy and cancer. The approach aims to downregulate DUX4 expression for therapeutic purposes.

SMCHD1, split inteins, gene expression, DUX4

Patent

ReaxFF molecular dynamics investigation of co-combustion between Zhundong coal and lignin

Published on 2026-02-25 by @OXFORD

Abstract: AbstractCo-combustion of coal and biomass offers a promising solution to reduce fossil fuel dependency. This study employs reactive force-field molecular dynamics (ReaxFF MD) to investigate the microscopic effects of temperature and mixing ratio on Zhundong coal–lignin co-combustion. Elevated temperatures significantly enhance the conversion from large molecules to smaller gaseous products (CO2, H2O), suppressing tar formation. Higher coal ratios (3:1, 2:1) favor reduced tar yield and increase[...]


Our summary: This study uses ReaxFF molecular dynamics to analyze the co-combustion of Zhundong coal and lignin. Elevated temperatures and higher coal ratios improve gaseous product yields while reducing tar formation. Reaction pathways indicate distinct contributions from coal oxidation, lignin pyrolysis, and the behavior of nitrogen and sulfur during combustion.

ReaxFF, molecular dynamics, co-combustion, Zhundong coal

Publication

A Comparative Study of CNN, BiLSTM, and GRU Architectures

Published on 2026-02-03 by Elias Tabane, Ernest Mnkandla, Zenghui Wang @MDPI

Abstract: DNA sequence classification is a fundamental problem in bioinformatics, playing an indispensable role in gene annotation and disease prediction. Whereas most deep learning models, such as CNNs, BiLSTM networks, and GRUs, have been found individually optimal, each of these methods excels in modeling a specific aspect of sequence data: local motifs, long-range dependencies, and efficient temporal modeling of the sequences. Here, we present and evaluate an ensemble model that integrates CNN, BiLSTM[...]


Our summary: This study evaluates CNN, BiLSTM, and GRU architectures for DNA sequence classification. An ensemble model combining these methods achieved a classification accuracy of 90.6%, outperforming individual models. The research highlights the effectiveness of hybrid deep learning in genomic data analysis.

CNN, BiLSTM, GRU, ensemble

Publication

取り上げるトピック: バイオインフォマティクス、計算技術、統計技術、生物学的データ、ゲノムデータセット、トランスクリプトームデータセット、プロテオームデータセット、メタボロームデータセット、配列アライメント、ゲノムアセンブリ、遺伝子発現プロファイリング、タンパク質構造予測、分子相互作用ネットワーク、機械学習、ハイスループットデータ処理、バリアント解釈、システムレベルモデリング、精密医療、ISO/IEC 27001、ISO 9001、ISO/IEC 25010、ISO 31000、およびISO 13485。

歴史的背景

2000
2002
2010
2013
2000
2000
2003
2010
2013-09-24

(日付が不明または関連性がない場合、例えば「流体力学」などでは、その注目すべき出現時期の概算値が提示されます。)

フルサイズの画像とダウンロードは、登録会員のみが100%無料で利用できます。